Skip to content 
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified. more
| Time Frame | LABU | S&P500 |
|---|---|---|
| 1-Week Return | -1.01% | 1.24% |
| 1-Month Return | -12.18% | 1.17% |
| 3-Month Return | -15.6% | 3.14% |
| 6-Month Return | 51% | 17.61% |
| 1-Year Return | 148.8% | 15.37% |
| 3-Year Return | 254.52% | 82.69% |
| 5-Year Return | -75.42% | 78.96% |
| 10-Year Return | -74.2% | 259.83% |
| Stock name | Ticker | Weight |
|---|---|---|
 SPSIBI SWAP ASSET LEG (SPSIBIUBL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIUBL. | 16.13% |
 SPSIBI SWAP ASSET LEG (SPSIBIMLL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIMLL. | 14.69% |
 SPSIBI SWAP ASSET LEG (SPSIBICTL) | SPSIBI.SWAP.ASSET.LEG..SPSIBICTL. | 13.4% |
 SPSIBI SWAP ASSET LEG (SPSIBIBCL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIBCL. | 11.66% |
 SPSIBI SWAP ASSET LEG (SPSIBIJPL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIJPL. | 9.89% |
 GOLDMAN FINL SQ TRSRY INST 506 | GOLDMAN.FINL.SQ.TRSRY.INST.506 | 5.94% |
 DREYFUS GOVT CASH MAN INS | DREYFUS.GOVT.CASH.MAN.INS | 2.07% |
 SPSIBI SWAP ASSET LEG (SPSIBIBPL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIBPL. | 1.34% |
 SPSIBI SWAP ASSET LEG (SPSIBIGSL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIGSL. | 0.87% |
 TWIST BIOSCIENCE CORP | TWST | 0.53% |
 MODERNA INC | MRNA | 0.49% |
 NATERA INC | NTRA | 0.43% |
 UNITED THERAPEUTICS CORP | UTHR | 0.4% |
 IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.38% |
 BIOGEN INC | BIIB | 0.37% |
 AMGEN INC | AMGN | 0.37% |
 ABBVIE INC | ABBV | 0.36% |
 SPYRE THERAPEUTICS INC | SYRE | 0.36% |
 CRISPR THERAPEUTICS AG | CRSP | 0.36% |
 GILEAD SCIENCES INC | GILD | 0.36% |
 HALOZYME THERAPEUTICS INC | HALO | 0.35% |
 EXELIXIS INC | EXEL | 0.35% |
 REVOLUTION MEDICINES INC | RVMD | 0.35% |
 TG THERAPEUTICS INC | TGTX | 0.34% |
 VERTEX PHARMACEUTICALS INC | VRTX | 0.34% |
 PROTAGONIST THERAPEUTICS INC | PTGX | 0.34% |
 PTC THERAPEUTICS INC | PTCT | 0.33% |
 KRYSTAL BIOTECH INC | KRYS | 0.33% |
 INCYTE CORP | INCY | 0.33% |
 MADRIGAL PHARMACEUTICALS INC | MDGL | 0.32% |
 ORUKA THERAPEUTICS INC | ORKA | 0.32% |
 REGENERON PHARMACEUTICALS | REGN | 0.32% |
 BIOMARIN PHARMACEUTICAL INC | BMRN | 0.32% |
 NEUROCRINE BIOSCIENCES INC | NBIX | 0.32% |
 ALNYLAM PHARMACEUTICALS INC | ALNY | 0.31% |
 ALKERMES PLC | ALKS | 0.31% |
 CYTOKINETICS INC | CYTK | 0.31% |
 GRAIL INC | GRAL | 0.31% |
 BRIDGEBIO PHARMA INC | BBIO | 0.31% |
 TRAVERE THERAPEUTICS INC | TVTX | 0.3% |
 KODIAK SCIENCES INC | KOD | 0.3% |
 ROIVANT SCIENCES LTD | ROIV | 0.3% |
 INSMED INC | INSM | 0.3% |
 COGENT BIOSCIENCES INC | COGT | 0.29% |
 PRAXIS PRECISION MEDICINES I | PRAX | 0.29% |
 ERASCA INC | ERAS | 0.29% |
 DIANTHUS THERAPEUTICS INC | DNTH | 0.29% |
 KYMERA THERAPEUTICS INC | KYMR | 0.28% |
 IONIS PHARMACEUTICALS INC | IONS | 0.28% |
 ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.28% |
 VAXCYTE INC | PCVX | 0.26% |
 RHYTHM PHARMACEUTICALS INC | RYTM | 0.26% |
 IMMUNITYBIO INC | IBRX | 0.26% |
 CG ONCOLOGY INC | CGON | 0.25% |
 VIKING THERAPEUTICS INC | VKTX | 0.25% |
 MIRUM PHARMACEUTICALS INC | MIRM | 0.24% |
 VERACYTE INC | VCYT | 0.24% |
 TANGO THERAPEUTICS INC | TNGX | 0.24% |
 CELCUITY INC | CELC | 0.21% |
 RELAY THERAPEUTICS INC | RLAY | 0.21% |
 CAREDX INC | CDNA | 0.21% |
 SCHOLAR ROCK HOLDING CORP | SRRK | 0.2% |
 BEAM THERAPEUTICS INC | BEAM | 0.2% |
 ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.18% |
 ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.18% |
 HYPERLIQUID STRATEGIES | PURR | 0.17% |
 IMMUNOVANT INC | IMVT | 0.17% |
 DYNE THERAPEUTICS INC | DYN | 0.16% |
 RECURSION PHARMACEUTICALS-A | RXRX | 0.16% |
 SELLAS LIFE SCIENCES GROUP I | SLS | 0.15% |
 DENALI THERAPEUTICS INC | DNLI | 0.15% |
 SUMMIT THERAPEUTICS INC | SMMT | 0.14% |
 IDEAYA BIOSCIENCES INC | IDYA | 0.14% |
 VERA THERAPEUTICS INC | VERA | 0.14% |
 BIOCRYST PHARMACEUTICALS INC | BCRX | 0.13% |
 AGIOS PHARMACEUTICALS INC | AGIO | 0.13% |
 ABSCI CORP | ABSI | 0.13% |
 ARCUS BIOSCIENCES INC | RCUS | 0.12% |
 SAREPTA THERAPEUTICS INC | SRPT | 0.12% |
 INTELLIA THERAPEUTICS INC | NTLA | 0.12% |
 CELLDEX THERAPEUTICS INC | CLDX | 0.12% |
 NURIX THERAPEUTICS INC | NRIX | 0.12% |
 ACADIA PHARMACEUTICALS INC | ACAD | 0.12% |
 NOVAVAX INC | NVAX | 0.12% |
 BIOHAVEN LTD | BHVN | 0.12% |
 PALVELLA THERAPEUTICS INC | PVLA | 0.11% |
 VIRIDIAN THERAPEUTICS INC | VRDN | 0.11% |
 UNIQURE NV | QURE | 0.11% |
 PRECIGEN INC | PGEN | 0.11% |
 SYNDAX PHARMACEUTICALS INC | SNDX | 0.11% |
 NEKTAR THERAPEUTICS | NKTR | 0.11% |
 DISC MEDICINE INC | IRON | 0.11% |
 ADMA BIOLOGICS INC | ADMA | 0.11% |
 VERICEL CORP | VCEL | 0.1% |
 IMMUNOME INC | IMNM | 0.1% |
 MINERALYS THERAPEUTICS INC | MLYS | 0.08% |
 STOKE THERAPEUTICS INC | STOK | 0.08% |
 REPLIMUNE GROUP INC | REPL | 0.08% |
 XENCOR INC | XNCR | 0.08% |
 INHIBRX BIOSCIENCES INC | INBX | 0.08% |
 ANAPTYSBIO INC | ANAB | 0.07% |
 ORIC PHARMACEUTICALS INC | ORIC | 0.07% |
 FIRST TRACKS BIOTHERAPEUTICS | TRAX | 0.07% |
 ZENAS BIOPHARMA INC | ZBIO | 0.07% |
 VIR BIOTECHNOLOGY INC | VIR | 0.07% |
 MANNKIND CORP | MNKD | 0.07% |
 KURA ONCOLOGY INC | KURA | 0.06% |
 ARRIVENT BIOPHARMA INC | AVBP | 0.06% |
 GOLDMAN SACHS FIN GOV 465 INSTITUT | GOLDMAN.SACHS.FIN.GOV.465.INSTITUT | 0.06% |
 ARDELYX INC | ARDX | 0.06% |
 TAYSHA GENE THERAPIES INC | TSHA | 0.06% |
 TYRA BIOSCIENCES INC | TYRA | 0.06% |
 ANNEXON INC | ANNX | 0.06% |
 MONTE ROSA THERAPEUTICS INC | GLUE | 0.06% |
 JADE BIOSCIENCES INC | JBIO | 0.06% |
 RIGEL PHARMACEUTICALS INC | RIGL | 0.05% |
 CANDEL THERAPEUTICS INC | CADL | 0.05% |
 AVALO THERAPEUTICS INC | AVTX | 0.05% |
 GERON CORP | GERN | 0.05% |
 IMMIX BIOPHARMA INC | IMMX | 0.05% |
 BICARA THERAPEUTICS INC | BCAX | 0.05% |
 CORVUS PHARMACEUTICALS INC | CRVS | 0.05% |
 VOR BIOPHARMA INC | VOR | 0.05% |
 JANUX THERAPEUTICS INC | JANX | 0.05% |
 CULLINAN THERAPEUTICS INC | CGEM | 0.04% |
 VERASTEM INC | VSTM | 0.04% |
 OLEMA PHARMACEUTICALS INC | OLMA | 0.04% |
 4D MOLECULAR THERAPEUTICS IN | FDMT | 0.04% |
 SAVARA INC | SVRA | 0.04% |
 HEMAB THERAPEUTICS HOLDINGS | COAG | 0.04% |
 CAPRICOR THERAPEUTICS INC | CAPR | 0.04% |
 SANA BIOTECHNOLOGY INC | SANA | 0.04% |
 ACHIEVE LIFE SCIENCES INC | ACHV | 0.04% |
 REGENXBIO INC | RGNX | 0.04% |
 DAMORA THERAPEUTICS INC | DAMORA.THERAPEUTICS.INC | 0.03% |
 ALLOGENE THERAPEUTICS INC | ALLO | 0.03% |
 KAILERA THERAPEUTICS INC | KLRA | 0.03% |
 CYTOMX THERAPEUTICS INC | CTMX | 0.03% |
 ARBUTUS BIOPHARMA CORP | ABUS | 0.03% |
 SHATTUCK LABS INC | STTK | 0.03% |
 IRONWOOD PHARMACEUTICALS INC | IRWD | 0.03% |
 ALTIMMUNE INC | ALT | 0.03% |
 SOLID BIOSCIENCES INC | SLDB | 0.03% |
 CLIMB BIO INC | CLYM | 0.03% |
 SAGIMET BIOSCIENCES INC-A | SGMT | 0.03% |
 MYRIAD GENETICS INC | MYGN | 0.03% |
 DESIGN THERAPEUTICS INC | DSGN | 0.03% |
 OCUGEN INC | OCGN | 0.03% |
 PRIME MEDICINE INC | PRME | 0.03% |
 MONOPAR THERAPEUTICS INC | MNPR | 0.03% |
 EDITAS MEDICINE INC | EDIT | 0.03% |
 EMERGENT BIOSOLUTIONS INC | EBS | 0.02% |
 AKTIS ONCOLOGY INC | AKTS | 0.02% |
 CABALETTA BIO INC | CABA | 0.02% |
 ARS PHARMACEUTICALS INC | SPRY | 0.02% |
 VANDA PHARMACEUTICALS INC | VNDA | 0.02% |
 MIMEDX GROUP INC | MDXG | 0.02% |
 PROTHENA CORP PLC | PRTA | 0.02% |
 NEUROGENE INC | NGNE | 0.02% |
 ASSEMBLY BIOSCIENCES INC | ASMB | 0.02% |
 OVID THERAPEUTICS INC | OVID | 0.02% |
 FAETH THERAPEUTICS INC | FTH | 0.01% |
 LEXEO THERAPEUTICS INC | LXEO | 0.01% |
 AURA BIOSCIENCES INC | AURA | 0.01% |
 DREYFUS TRSRY SECURITIES CASH MGMT | DREYFUS.TRSRY.SECURITIES.CASH.MGMT | 0.01% |
 CRESCENT BIOPHARMA INC | CBIO | 0.01% |
 COMPASS THERAPEUTICS INC | CMPX | 0.01% |
 BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 0.01% |
 OMNIAB INC - 15.00 EARNOUT | 2200964 | 0% |
 INHIBRX INC CVR | INHIBRX.INC.CVR | 0% |
 OMNIAB INC - 12.5 EARNOUT | 2200963 | 0% |
 VERVE THERAPEUTICS INC (CVR) | VERVE.THERAPEUTICS.INC..CVR. | 0% |
 NOVOB DC CVR | NOVOB.DC.CVR | 0% |
| Sector | Weight |
|---|---|
|
Health care | 99.24% |
|
Financials | 0.76% |
Direxion Daily S&P Biotech Bull 3X Shares (LABU) share price today is $237.94.
Yes, Indians can buy shares of Direxion Daily S&P Biotech Bull 3X Shares (LABU) on Vested. To buy LABU from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Direxion Daily S&P Biotech Bull 3X Shares (LABU) on Vested. You can start investing in Direxion Daily S&P Biotech Bull 3X Shares (LABU) with a minimum investment of $1.
The 52-week high price of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is $341.93. The 52-week low price of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is $99.66.
The stock symbol (or ticker) of Direxion Daily S&P Biotech Bull 3X Shares is LABU.
Yes, you can setup SIP in Direxion Daily S&P Biotech Bull 3X Shares shares. Follow the below steps to create the SIP:
Here is the historical performance of LABU on the Vested app.
The expense ratio of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is 0.96%.
Link copied 
